For these purposes, NOTCH1Mutated T-ALL LIC-engrafted mice were treated with a selective NOTCH1-NRR/Fc mAb (hN1 mAb) that specifically inhibits NOTCH1 receptor signaling (Figures S2A and B). This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.